Official source Data mirrored from Centers for Medicare & Medicaid Services Open Payments · General Payments · CMS publication 2026-06-30 View official record

Covered recipient · General Payments record

CARRIE W COBB

Allopathic & Osteopathic Physicians Dermatology

NPI
1770732232
CMS profile
612830
Location
LYNCHBURG, VA

A name match is not confirmation of identity. CMS publishes records for different people under similar names; the NPI, specialty, and location shown on this page are the CMS-published fields that distinguish them.

Saved items

Saved only in this browser. No account or alerts.

Filter and download payment records

General Payments · PY2019 · Entire year

$1,576.76

71 records · 0 disputed

Summary and payment records

  • CMS publication 2026-06-30
Read the payment records

“Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.”

— Centers for Medicare & Medicaid Services, Open Payments

A reported payment reflects a financial relationship a company disclosed. It does not indicate wrongdoing or a conflict of interest, and it says nothing about the quality of a provider's care.

These records are submitted to CMS and attested to by the reporting companies. CMS publishes them as reported; this site mirrors them without independent verification.

A payment attributed to a provider may have been made to a third party — a hospital, practice, or research institution — rather than paid to the provider personally.

How these totals are calculated
  • This total is the sum of the individual General Payments record amounts CMS published for the labeled program year(s); each record amount is used unmodified. The total itself is computed by this site. Nothing is estimated, weighted, or combined across categories.
  • General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
  • Methodology & Data — sourcing, labeling, and limitations.

Provider summaries generated . CMS updates this data on an annual cycle, and corrections or successful disputes made at CMS may not yet appear here. The official CMS record is authoritative for the current state. View the official CMS record ↗

By nature of payment

PY2019 · entire year · sorted by reported total

Nature of paymentAmountRecords
Food and Beverage $1,546.76 70
Education $30.00 1

By paying entity

PY2019 · entire year · sorted by reported total

Page 1 of 2; records 1–50 of 71 matching records. This page contains 50 records (maximum 50), not the full filtered export. Use the CSV download for all matching records.

IndustryPayments · General Payments

CARRIE W COBB

NPI 1770732232 · CMS profile ID 612830

Allopathic & Osteopathic Physicians / Dermatology

LYNCHBURG, VA

A name match is not confirmation of identity. CMS publishes records for different people under similar names; the NPI, specialty, and location shown on this page are the CMS-published fields that distinguish them.

A payment attributed to a provider may have been made to a third party — a hospital, practice, or research institution — rather than paid to the provider personally.

General Payments, PY2019; Recipient scope: Physicians and non-physician practitioners; Reporting company: All reporting companies; Nature of payment: All payment types

Data edition: cms-20260630-workflow-20261105-v2; CMS publication: 2026-06-30; records imported: 2026-11-05T09:06:52.159882+00:00

Page 1 of 2; records 1–50 of 71 matching records. This page contains 50 records (maximum 50), not the full filtered export.

Filtered page: https://industrypayments.org/provider/npi-1770732232?year=2019&recipient=provider#records-h

CMS source: https://openpaymentsdata.cms.gov/dataset/4e54dd6c-30f8-4f86-86a7-3c109a89528e

Cite these filtered records

The citation includes this program year, filters, data edition, and page of results.

Plain
CARRIE W COBB, NPI 1770732232, CMS profile ID 612830. General Payments, PY2019; Recipient scope: Physicians and non-physician practitioners; Reporting company: All reporting companies; Nature of payment: All payment types. Data edition: cms-20260630-workflow-20261105-v2; CMS publication: 2026-06-30; records imported: 2026-11-05T09:06:52.159882+00:00. Page 1 of 2; records 1–50 of 71 matching records. This page contains 50 records (maximum 50), not the full filtered export. IndustryPayments. https://industrypayments.org/provider/npi-1770732232?year=2019&recipient=provider#records-h. Source: https://openpaymentsdata.cms.gov/dataset/4e54dd6c-30f8-4f86-86a7-3c109a89528e.
APA 7
IndustryPayments. (2026). CARRIE W COBB, NPI 1770732232, CMS profile ID 612830. General Payments, PY2019; Recipient scope: Physicians and non-physician practitioners; Reporting company: All reporting companies; Nature of payment: All payment types. Data edition: cms-20260630-workflow-20261105-v2; CMS publication: 2026-06-30; records imported: 2026-11-05T09:06:52.159882+00:00. Page 1 of 2; records 1–50 of 71 matching records. This page contains 50 records (maximum 50), not the full filtered export. [Filtered data set page]. https://industrypayments.org/provider/npi-1770732232?year=2019&recipient=provider#records-h. Source: https://openpaymentsdata.cms.gov/dataset/4e54dd6c-30f8-4f86-86a7-3c109a89528e.
Bluebook
CARRIE W COBB, NPI 1770732232, CMS profile ID 612830, IndustryPayments, General Payments, PY2019; Recipient scope: Physicians and non-physician practitioners; Reporting company: All reporting companies; Nature of payment: All payment types (Data edition: cms-20260630-workflow-20261105-v2; CMS publication: 2026-06-30; records imported: 2026-11-05T09:06:52.159882+00:00). Page 1 of 2; records 1–50 of 71 matching records. This page contains 50 records (maximum 50), not the full filtered export. Source: https://openpaymentsdata.cms.gov/dataset/4e54dd6c-30f8-4f86-86a7-3c109a89528e. https://industrypayments.org/provider/npi-1770732232?year=2019&recipient=provider#records-h.

Centers for Medicare & Medicaid Services, Open Payments

Citation formats are provided for reference; check the requirements of your publication.

Payment records · PY2019

Ordering applied by this site (date, newest first, then paying entity) · record values are shown as CMS published them

General Payments · PY2019 · Physicians and non-physician practitioners · CMS publication 2026-06-30

71 matching records · $1,576.76 reported total · 0 disputed

Nature of payment: All payment types

Records imported here (UTC).

Link to these filtered records · CMS source dataset ↗

Download all 71 matching records (CSV)

CSV includes CMS record IDs, source and publication dates, the data edition, and a link to these filters. Formula-like text cells are prefixed with an apostrophe for spreadsheet safety.

Showing records 1–50 of 71.

Paying entityAmountDate Nature of paymentDispute statusPublication flagsPublished Record IDSource
AbbVie, Inc. $21.1712/03/2019 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 648096569 CMS
GENZYME CORPORATION $11.8811/21/2019 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 694236025 CMS
AbbVie, Inc. $23.0811/12/2019 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 648096431 CMS
GENZYME CORPORATION $16.7711/08/2019 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 694196351 CMS
Novartis Pharmaceuticals Corporation $10.0911/07/2019 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 658871913 CMS
AbbVie, Inc. $90.1011/06/2019 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 648096567 CMS
AbbVie, Inc. $19.9111/04/2019 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 648096451 CMS
Galderma Laboratories, L.P. $12.6710/30/2019 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 687671951 CMS
AbbVie, Inc. $18.0710/17/2019 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 648096519 CMS
PFIZER INC. $13.1110/16/2019 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 673178433 CMS
Novartis Pharmaceuticals Corporation $15.7910/14/2019 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 658871908 CMS
AbbVie, Inc. $21.3710/11/2019 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 648096559 CMS
Novartis Pharmaceuticals Corporation $101.6210/03/2019 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 658871899 CMS
GENZYME CORPORATION $21.0710/02/2019 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 694204793 CMS
AbbVie, Inc. $21.1610/01/2019 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 648096551 CMS
Mayne Pharma Inc. $10.8909/27/2019 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 705492511 CMS
UCB, Inc. $19.4709/27/2019 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 688307979 CMS
Celgene Corporation $13.5509/12/2019 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 673024943 CMS
AbbVie, Inc. $22.4109/09/2019 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 648096547 CMS
AbbVie, Inc. $20.3609/05/2019 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 648096447 CMS
Novartis Pharmaceuticals Corporation $12.0008/29/2019 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 658871895 CMS
GENZYME CORPORATION $22.7608/23/2019 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 694119173 CMS
AbbVie, Inc. $22.6608/15/2019 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 648096541 CMS
AbbVie, Inc. $18.6808/09/2019 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 648096517 CMS
AbbVie, Inc. $20.3508/05/2019 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 648096439 CMS
PFIZER INC. $13.1107/25/2019 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 672316879 CMS
AbbVie, Inc. $19.6007/22/2019 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 648096433 CMS
DUSA Pharmaceuticals, Inc. $17.1607/19/2019 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 704631923 CMS
Janssen Biotech, Inc. $11.6407/18/2019 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 658376006 CMS
UCB, Inc. $18.9607/17/2019 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 688294773 CMS
PruGen, Inc. Pharmaceuticals $8.7007/15/2019 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 707758563 CMS
Novartis Pharmaceuticals Corporation $15.6907/11/2019 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 658795607 CMS
AbbVie, Inc. $45.9406/27/2019 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 648096515 CMS
Novartis Pharmaceuticals Corporation $10.2606/27/2019 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 658871903 CMS
Sun Pharmaceutical Industries Inc. $21.7906/20/2019 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 704631921 CMS
Galderma Laboratories, L.P. $15.9306/18/2019 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 687671949 CMS
AbbVie, Inc. $19.4906/17/2019 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 648096535 CMS
AbbVie, Inc. $21.8406/13/2019 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 648096531 CMS
GENZYME CORPORATION $12.3406/07/2019 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 694053567 CMS
AbbVie, Inc. $0.3205/29/2019 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 648096507 CMS
AbbVie, Inc. $16.7205/28/2019 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 648096503 CMS
AbbVie, Inc. $22.2505/23/2019 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 648096529 CMS
PFIZER INC. $14.6805/17/2019 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 672080366 CMS
Novartis Pharmaceuticals Corporation $12.9805/16/2019 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 658871889 CMS
AbbVie, Inc. $22.0005/07/2019 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 648096521 CMS
Genentech USA, Inc. $21.3305/01/2019 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 681221547 CMS
AbbVie, Inc. $23.0704/18/2019 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 648096499 CMS
DUSA Pharmaceuticals, Inc. $42.3304/15/2019 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 704631925 CMS
SANOFI-AVENTIS U.S. LLC $22.9804/12/2019 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 694017267 CMS
AbbVie, Inc. $21.1604/10/2019 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 648096491 CMS

By program year

All program years on this page · sorted by year

Program yearAmountRecords
PY2019 $1,576.76 71
PY2020 $452.78 24
PY2021 $756.82 43
PY2022 $1,473.25 82
PY2023 $1,140.39 66
PY2024 $1,276.84 63
PY2025 $1,300.92 67

Source & provenance

Dataset
CMS Open Payments — General Payments
Publisher of source data
Centers for Medicare & Medicaid Services
CMS publication date
2026-06-30
Program years on this page
2019, 2020, 2021, 2022, 2023, 2024, 2025
Source files and profile matching
Generated from
OP_DTL_GNRL_PGYR2025_P06302026_06032026.csv

One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.

Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.

Research Payments

One row per program year and role, newest year first · amounts for the two roles are never added together

Program yearRoleAmountRecords
PY2025 Recipient $2,925.00 1
PY2025 Principal investigator $114,849.62 28
PY2024 Principal investigator $62,328.66 17
PY2023 Principal investigator $244,801.75 20
PY2022 Principal investigator $429,473.77 15

Research Payments are a separate CMS dataset, shown here separately and never added to General Payments. A research payment is often made to an institution, with this provider named as a principal investigator; each record states which role applies.

“If you are a physician who served as a principal investigator on a research study, you may see the payments associated with that research study listed under your name. This does not necessarily mean the payments are attributed to you. The dollar amount of the record corresponds to the total payment; the amounts are not attributed to each individual on the record.”

— Centers for Medicare & Medicaid Services, Open Payments Frequently Asked Questions, FAQ #12224

Research Payments records · PY2024

Ordering applied by this site (date, newest first, then paying entity) · record values are shown as CMS published them

17 records in PY2024

Research Payments records (CSV)

RolePaying entityAmount DateRecipientStudy Dispute statusPublishedRecord ID
Principal investigator 1 PFIZER INC. $3,037.42 12/05/2024 Non-covered Recipient Entity
The Education Research Foundation Inc
A PHASE 3 RANDOMIZED DOUBLEBLIND 52WEEK PLACEBOCONTROLLED MULTICENTER STUDY WITH A DOUBLEBLIND 52WEEK EXTENSION PERIOD WITH RANDOMIZED DOSE UPDOSE DOWN TITRATION INVESTIGATING THE EFFICACY SAFETY AND TOLERABILITY OF RITLECITINIB IN ADULT PARTICIPANTS WITH NONSEGMENTAL VITILIGO No dispute reported 06/30/2026 1130959336
Principal investigator 1 Amgen Inc. $4,201.00 11/26/2024 Non-covered Recipient Entity
EDUCATION AND RESEARCH FOUNDATION INC
ASCEND P3 AD Extension No dispute reported 06/30/2026 1096309187
Principal investigator 1 PFIZER INC. $911.95 11/05/2024 Non-covered Recipient Entity
The Education Research Foundation Inc
A PHASE 3 RANDOMIZED DOUBLEBLIND 52WEEK PLACEBOCONTROLLED MULTICENTER STUDY WITH A DOUBLEBLIND 52WEEK EXTENSION PERIOD WITH RANDOMIZED DOSE UPDOSE DOWN TITRATION INVESTIGATING THE EFFICACY SAFETY AND TOLERABILITY OF RITLECITINIB IN ADULT PARTICIPANTS WITH NONSEGMENTAL VITILIGO No dispute reported 06/30/2026 1130969397
Principal investigator 1 PFIZER INC. $2,930.85 10/03/2024 Non-covered Recipient Entity
The Education Research Foundation Inc
A PHASE 3 RANDOMIZED DOUBLEBLIND 52WEEK PLACEBOCONTROLLED MULTICENTER STUDY WITH A DOUBLEBLIND 52WEEK EXTENSION PERIOD WITH RANDOMIZED DOSE UPDOSE DOWN TITRATION INVESTIGATING THE EFFICACY SAFETY AND TOLERABILITY OF RITLECITINIB IN ADULT PARTICIPANTS WITH NONSEGMENTAL VITILIGO No dispute reported 06/30/2026 1130969403
Principal investigator 1 Amgen Inc. $415.40 09/25/2024 Non-covered Recipient Entity
EDUCATION AND RESEARCH FOUNDATION INC
ASCEND P3 AD Extension No dispute reported 06/30/2026 1096309193
Principal investigator 1 ABBVIE INC. $2,078.29 09/04/2024 Non-covered Recipient Entity
INTERSPOND LLC
A Study to Assess Change in Disease Activity and Adverse Events of Oral Upadacitinib in Adult and Adolescent Participants With Moderate to Severe Hidradenitis Suppurativa Who Have Failed Anti-TNF Therapy (Step-Up HS) No dispute reported 06/30/2026 1100740456
Principal investigator 1 PFIZER INC. $4,654.53 08/23/2024 Non-covered Recipient Entity
The Education Research Foundation Inc
A PHASE 3 RANDOMIZED DOUBLEBLIND 52WEEK PLACEBOCONTROLLED MULTICENTER STUDY WITH A DOUBLEBLIND 52WEEK EXTENSION PERIOD WITH RANDOMIZED DOSE UPDOSE DOWN TITRATION INVESTIGATING THE EFFICACY SAFETY AND TOLERABILITY OF RITLECITINIB IN ADULT PARTICIPANTS WITH NONSEGMENTAL VITILIGO No dispute reported 06/30/2026 1131018399
Principal investigator 1 ABBVIE INC. $3,283.89 07/05/2024 Non-covered Recipient Entity
INTERSPOND LLC
A Study to Assess Change in Disease Activity and Adverse Events of Oral Upadacitinib in Adult and Adolescent Participants With Moderate to Severe Hidradenitis Suppurativa Who Have Failed Anti-TNF Therapy (Step-Up HS) No dispute reported 06/30/2026 1100727814
Principal investigator 1 ABBVIE INC. $1,801.55 06/06/2024 Non-covered Recipient Entity
INTERSPOND LLC
A Study to Assess Change in Disease Activity and Adverse Events of Oral Upadacitinib in Adult and Adolescent Participants With Moderate to Severe Hidradenitis Suppurativa Who Have Failed Anti-TNF Therapy (Step-Up HS) No dispute reported 06/30/2026 1100722888
Principal investigator 1 ABBVIE INC. $2,468.74 05/09/2024 Non-covered Recipient Entity
INTERSPOND LLC
A Study to Assess Change in Disease Activity and Adverse Events of Oral Upadacitinib in Adult and Adolescent Participants With Moderate to Severe Hidradenitis Suppurativa Who Have Failed Anti-TNF Therapy (Step-Up HS) No dispute reported 06/30/2026 1100717730
Principal investigator 1 Amgen Inc. $8,514.00 04/20/2024 Non-covered Recipient Entity
EDUCATION AND RESEARCH FOUNDATION INC
ASCEND P3 AD Extension No dispute reported 06/30/2026 1096309191
Principal investigator 1 PFIZER INC. $670.00 04/09/2024 Non-covered Recipient Entity
The Education Research Foundation Inc
A PHASE 3 RANDOMIZED DOUBLEBLIND 52WEEK PLACEBOCONTROLLED MULTICENTER STUDY WITH A DOUBLEBLIND 52WEEK EXTENSION PERIOD WITH RANDOMIZED DOSE UPDOSE DOWN TITRATION INVESTIGATING THE EFFICACY SAFETY AND TOLERABILITY OF RITLECITINIB IN ADULT PARTICIPANTS WITH NONSEGMENTAL VITILIGO No dispute reported 06/30/2026 1131091964
Principal investigator 1 ABBVIE INC. $6,395.16 03/07/2024 Non-covered Recipient Entity
INTERSPOND LLC
A Study to Assess Change in Disease Activity and Adverse Events of Oral Upadacitinib in Adult and Adolescent Participants With Moderate to Severe Hidradenitis Suppurativa Who Have Failed Anti-TNF Therapy (Step-Up HS) No dispute reported 06/30/2026 1100705984
Principal investigator 1 PFIZER INC. $3,863.00 03/06/2024 Non-covered Recipient Entity
The Education Research Foundation Inc
A PHASE 3 RANDOMIZED DOUBLEBLIND 52WEEK PLACEBOCONTROLLED MULTICENTER STUDY WITH A DOUBLEBLIND 52WEEK EXTENSION PERIOD WITH RANDOMIZED DOSE UPDOSE DOWN TITRATION INVESTIGATING THE EFFICACY SAFETY AND TOLERABILITY OF RITLECITINIB IN ADULT PARTICIPANTS WITH NONSEGMENTAL VITILIGO No dispute reported 06/30/2026 1131090713
Principal investigator 1 PFIZER INC. $8,133.00 01/26/2024 Non-covered Recipient Entity
The Education Research Foundation Inc
A PHASE 3 RANDOMIZED DOUBLEBLIND 52WEEK PLACEBOCONTROLLED MULTICENTER STUDY WITH A DOUBLEBLIND 52WEEK EXTENSION PERIOD WITH RANDOMIZED DOSE UPDOSE DOWN TITRATION INVESTIGATING THE EFFICACY SAFETY AND TOLERABILITY OF RITLECITINIB IN ADULT PARTICIPANTS WITH NONSEGMENTAL VITILIGO No dispute reported 06/30/2026 1131094258
Principal investigator 1 ABBVIE INC. $3,915.46 01/10/2024 Non-covered Recipient Entity
INTERSPOND LLC
A Study to Assess Change in Disease Activity and Adverse Events of Oral Upadacitinib in Adult and Adolescent Participants With Moderate to Severe Hidradenitis Suppurativa Who Have Failed Anti-TNF Therapy (Step-Up HS) No dispute reported 06/30/2026 1100699573
Principal investigator 1 Amgen Inc. $5,054.42 01/03/2024 Non-covered Recipient Entity
EDUCATION AND RESEARCH FOUNDATION INC
ASCEND P3 AD Extension No dispute reported 06/30/2026 1096309189